SG Americas Securities, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2024$2,144
-0.3%
21,8000.0%0.01%
-50.0%
Q4 2023$2,150
-53.1%
21,800
-53.4%
0.02%
-61.5%
Q3 2023$4,588
+830.6%
46,800
+836.0%
0.05%
+1200.0%
Q2 2023$493
-91.7%
5,000
-91.5%
0.00%
-94.2%
Q1 2023$5,967
-99.9%
58,800
+31.5%
0.07%
+130.0%
Q3 2020$4,704,000
+284.0%
44,720
+347.2%
0.03%
+200.0%
Q2 2020$1,225,000
+16.7%
10,0000.0%0.01%0.0%
Q1 2020$1,050,000
-0.8%
10,0000.0%0.01%0.0%
Q4 2019$1,059,000
+7.5%
10,0000.0%0.01%
+25.0%
Q3 2019$985,000
-32.4%
10,000
-28.6%
0.01%
-20.0%
Q2 2019$1,457,000
+42.0%
14,000
+40.0%
0.01%
+11.1%
Q1 2019$1,026,000
+2.9%
10,0000.0%0.01%0.0%
Q4 2018$997,000
-48.2%
10,000
-44.4%
0.01%
-35.7%
Q3 2018$1,923,000
+5.5%
18,0000.0%0.01%
-12.5%
Q2 2018$1,823,000
+7.9%
18,0000.0%0.02%
+14.3%
Q1 2018$1,690,000
+69.7%
18,000
+80.0%
0.01%
+55.6%
Q4 2017$996,000
-34.5%
10,000
-33.3%
0.01%
-30.8%
Q3 2017$1,520,00015,0000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2023
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
LOOMIS SAYLES & CO L P 901,591$69,512,0000.09%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders